MARKET RADAR
SENSEX     NIFTY      Refresh
You are here : MONEYCONTROL > MARKETS > SHARE PRICE > PHARMACEUTICALS > COMPANY INFO - PARABOLIC DRUGS

Parabolic Drugs

BSE: 533211 | NSE: PARABDRUGS | ISIN: INE618H01016 | SECTOR: PHARMACEUTICALS
OR
Add to Watchist
Have you invested in these stocks? You can track them better in your Portfolio
LIVE
BSE
Jun 19, 17:00
4.76
0.22 (+4.85%)
VOLUME 5,701
AVERAGE VOLUME
5-Day 11,534
10-Day 12,142
30-Day 16,212
VOLUME SHOCKER
5-Day 11,534
10-Day 12,142
30-Day 16,212
Prev. Close
4.54
Open Price
4.70
Bid PRICE (QTY.)
0.00 (0)
Offer PRICE (Qty.)
0.00 (0)
Today’s Low/High 4.60 4.76
52 Wk Low/High 4.38 30.65
LIVE
NSE
Jun 19, 17:00
4.75
0.20 (+4.40%)
VOLUME 17,548
AVERAGE VOLUME
5-Day 33,124
10-Day 24,505
30-Day 15,663
VOLUME SHOCKER
5-Day 33,124
10-Day 24,505
30-Day 15,663
Prev. Close
4.55
Open Price
4.70
Bid PRICE (QTY.)
4.75 (4400)
Offer PRICE (Qty.)
0.00 (0)
Today’s Low/High 4.60 4.75
52 Wk Low/High 4.20 30.80
Action in Parabolic Drugs
MARKET CAP (Rs Cr)
29.46
*P/E
-
*BOOK VALUE (Rs)
46.64
DIV (%)
2.50%
Market Lot
1
INDUSTRY P/E
29.25
*EPS (TTM)
-
*P/C
-
*PRICE/BOOK
0.10
DIV YIELD.(%)
5.25%
FACE VALUE (Rs)
10.00
DELIVERABLES (%)
84.08 new
DELIVERY AVERAGES
3-Day 76.23%
5-Day 83.96%
8-Day 89.98%
* Based on standalone numbers
Track Parabolic Drugs on the go with moneycontrol app
EXPAND ALL COLLAPSE ALL
Would you bet on Parabolic Drugs today?
Test your strategy with virtual money on Moneybhai
Historic Prices & Simple Moving Averages
on
1 week  |  1 month  |  3 month  |  1 year  |  2 year
  1 Year Current %Gain / Loss
Open Price 25.00 4.70  
High Price 25.00 4.76  
Low Price 21.20 4.60  
Last Price 21.45 4.76 -77.81
Volume 7,217 5,701 -21.01
Simple Moving Averages
Days BSE NSE
30 5.93 5.99
50 6.38 6.40
150 8.82 8.82
200 12.89 12.88

Get Historical Stock Prices »

Click here to view the Open, High, Low, Close, Volume and Spread data for Parabolic Drugs

News/Videos & Announcements
Stock Advice & Research Reports
News Across the Web
Financials
Income Statement
(In Rs Cr)
  (Mar '13)
Quarterly
(Mar '13)
Yearly
Net Sales 57.57 768.79
Other Income 0.00 0.00
PBDIT -123.36 -70.22
Net Profit -98.67 -139.76

Annual Report

Download in PDF format 2012 |2010
Balance Sheet
(Mar '13)
(In Rs Cr)
Total Share Capital 61.89
Net Worth 428.41
Total Debt 522.38
Net Block 187.89
Investments 3.57
Net Current Assets 572.06
Total Assets 950.81
Peers
Peer Comparison
Company Name Last Price %
Change
52 wk
High
52 wk
Low
Market Cap
Sun Pharma 961.15 -1.02 1085.40 606.70 99,534.96
Dr Reddys Labs 2099.50 -1.53 2207.80 1555.00 35,657.17
Lupin 795.00 0.61 810.80 528.00 35,587.15
Cipla 379.85 0.03 435.00 316.00 30,498.97
GlaxoSmithKline 2471.65 1.77 2899.00 2005.00 20,935.62
More » 
Share Holding Pattern & Mutual Funds Holding
Share Holding Pattern in (%)
 Mar' 13Dec' 12Jun' 12Mar' 12
Promoter37.9237.9239.2339.22
FII14.1213.9614.2316.37
DII2.883.304.874.71
Others45.0844.8241.6739.70
Total100.00100.00100.00100.00
Mutual Funds Holding
Scheme No. of Shares
UTI Childrens Career Balanced Plan 297,545
Company Information
REGISTERED OFFICE
Address
S.C.O 99-100, Top Floor,,Sector 17 - B
City
Chandigarh
State
Chandigarh
Pin Code
160017
Tel. No.
0172-3914646 0172-3914647
Fax No.
0172-3914645
REGISTRARS
Name
Link Intime India Pvt. Ltd.
Address
C-13, Pannalal Silk Mills Compound, LBS Marg, Bhandup (W)
City
Mumbai - 400078
State
Maharashtra
Tel. No.
022-25963838, 25946970
Fax No.
022-25946969
MANAGEMENT
Name
Designation
Pranav Gupta
Managing Director
Vineet Gupta
Whole Time Director
Arun Mathur
Director
Ram Kumar
Director
Nikhil Goel
Director
Message Board & Community
Quick Links for Parabolic Drugs
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.